Merck KGaA Is Said to Plan $4 Billion Bond Sale to Fund Purchase

Merck KGaA, a German maker of drugs and electronics, is looking to sell around $4 billion of US investment-grade bonds to help fund its acquisition of SpringWorks Therapeutics Inc., according to people with knowledge of the matter.
The deal would be … [382 chars]